Pharsight

Drug patents opposed in 2019

Drug patents opposed in 2019 at the European Patent Office (EPO).

Patent Number Patent Title Company Recent Opposition Date Recent Opposition By Activity Alert
EP2756004B1 Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9) REGENERON PHARMACEUTICALS 27 Dec, 2019
AMGEN
(and 1 more)
EP2772500B1 Site-directed modification of FVIII BAYER HEALTHCARE LLC 27 Dec, 2019
(Expiration: Nov, 2025)
MARKS & CLERK
EP2667892B1 Rsv immunization regimen GLAXOSMITHKLINE BIOLOGICALS SA 27 Dec, 2019
(Expiration: Jan, 2032)
PFIZER
EP3041939B1 Recombinant marek's disease viruses and uses thereof CEVA SANT ANIMALE 24 Dec, 2019
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP3067066B1 Prevention and treatment of synucleinopathic and amyloidogenic disease PROTHENA BIOSCIENCES 24 Dec, 2019
EUROPEAN OPPOSITIONS
EP3262200B1 Process for producing low ash lactose using a clarifier with acid and device for carrying out the process SPX FLOW TECHNOLOGY DANMARK 23 Dec, 2019
GEA PROCESS ENGINEERING
EP2988733B1 Pharmaceutical composition containing crystalline macitentan SANDOZ 23 Dec, 2019
GILL JENNINGS & EVERY
EP3236938B1 Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol SANOVEL ILAC SANAYI VE TICARET AS 23 Dec, 2019
(Expiration: Dec, 2035)
RECKITT BENCKISER HEALTH
EP2861234B1 Progesterone formulations THERAPEUTICSMD INC 23 Dec, 2019
(Expiration: Jun, 2033)
RIECK
EP2200588B1 Compositions comprising lipophilic active compounds and method for their preparation SOLUBEST LTD 20 Dec, 2019
(Expiration: Sep, 2028)
DSM NUTRITIONAL PRODUCTS
EP2356981B1 Mascara containing aqueous dispersion of polyurethane and a hard wax LORAL 20 Dec, 2019
FA SCHWANHUER INDUSTRIE HOLDING
EP2944323B1 Agents for treating tumours, use and method thereof DINGFU BIOTARGET CO LTD 20 Dec, 2019
(Expiration: Jan, 2033)
MERCK PATENT
(and 2 more)
EP3038647B1 Combination therapy for the treatment of glioblastoma F HOFFMANN LA ROCHE AG 20 Dec, 2019
(Expiration: Aug, 2034)
NEUEFEIND
(and 1 more)
EP2569419B1 Differentiation of human embryonic stem cells JANSSEN BIOTECH INC 20 Dec, 2019
(Expiration: May, 2031)
SANOFI
EP2214679B1 Corticosteroid compositions MERITAGE PHARMA INC 19 Dec, 2019
(Expiration: Nov, 2028)
DR FALK PHARMA
(and 1 more)
EP3185845B1 Non-greasy personal care compositions COLGATE PALMOLIVE 19 Dec, 2019
HENKEL
EP2754440B1 Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis MITSUBISHI TANABE PHARMA CORP 19 Dec, 2019
(Expiration: Sep, 2032)
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP2488044B1 Allergy treatment using acid treated aqueous whey protein extract DAIRY AUSTRALIA 18 Dec, 2019
NUTRICIA
EP2252148B1 Methods for treating bowel diseases SALIX PHARMACEUTICALS 18 Dec, 2019
SANDOZ
(and 2 more)
EP3165220B1 Pharmaceutical composition containing an anti-nucleating agent MERCK SHARP & DOHME 17 Dec, 2019
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
(and 1 more)
EP2658513B2 Hair colouring composition KAO GERMANY 16 Dec, 2019
HENKEL
EP3351240B1 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione CELGENE 16 Dec, 2019
PRU
(and 3 more)
EP3034093B1 Compositions and methods of treating tumors UNIVERSITY OF PENNSYLVANIA PENN 13 Dec, 2019
(Expiration: Mar, 2019)
F HOFFMANN LA ROCHE
EP3030666B1 Compositions and methods for treatment of muscular dystrophy CONSIGLIO NAZIONALE DELLE RICHERCHE CNR 13 Dec, 2019
(Expiration: Jul, 2034)
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3165227B2 Composition for treating or preventing metabolic disease, containing, as active ingredient, extracellular vesicles derived from akkermansia muciniphila bacteria MD HEALTHCARE 13 Dec, 2019
ICOSA EUROPE
EP3093005B1 Octocrylene-free sunscreen comprising diethyl hexyl butamido triazone BEIERSDORF AG 13 Dec, 2019
(Expiration: May, 2036)
PLOUGMANN VINGTOFT
(and 6 more)
EP3090780B2 Process for the preparation of an oil-in-water emulsion DIVA BRANDS & PATENTS 12 Dec, 2019
HENKEL
EP3092226B1 Indazole compounds as irak4 inhibitors AURIGENE DISCOVERY TECHNOLOGIES LTD 11 Dec, 2019
(Expiration: Jan, 2035)
BAYER BAYER PHARMA
EP1893734B1 Near anhydrous consumer products comprising fragranced aminoplast capsules FIRMENICH SA 10 Dec, 2019
(Expiration: May, 2026)
GIVAUDAN
(and 3 more)
EP2859075B1 Biosolubilizer GIVAUDAN SA 09 Dec, 2019
(Expiration: May, 2033)
CRODA
(and 1 more)
EP3195853B1 Octocrylene-free solar protection formulation with diethylamino hydroxybenzoyl hexyl benzoate. BEIERSDORF AG 09 Dec, 2019
(Expiration: Jan, 2037)
EMIL KIESSLING
EP3103448B1 Pharmaceutical compositions comprising an s1p modulator NOVARTIS 09 Dec, 2019
(Expiration: Sep, 2027)
ZENTIVA
(and 6 more)
EP2196189B1 Cosmetic sunscreen compositions based on synergistic filter mixture and their use LOREAL SA 06 Dec, 2019
(Expiration: Nov, 2022)
COHAUSZ & FLORACK PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
(and 1 more)
EP3300721B1 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices NOVO NORDISK AS 06 Dec, 2019
(Expiration: Nov, 2024)
GENERICS UK
(and 4 more)
EP2198929B1 Hair dye or lightening composition comprising a fatty substance and a cationic polymer, and use thereof LOREAL 06 Dec, 2019
HENKEL
EP3297732B1 Anhydrous deodorant composition made from bicarbonate LABORATOIRES M & L 06 Dec, 2019
HENKEL
EP3262941B1 Isothiazolinone biocides enhanced by zinc ions ARCH CHEMICALS 06 Dec, 2019
THOR
EP1633766B1 Modified fluorinated nucleoside analogues GILEAD PHARMASSET LLC 05 Dec, 2019
(Expiration: Apr, 2024)
GILLARD
EP2198927B1 Composition comprising a fatty substance and a particular oxyethylene surfactant, dyeing or lightening process using it, and devices therefor LOREAL 05 Dec, 2019
HENKEL
EP3047843B1 First agent for oxidation hair dye and method for stabilizing color tone of oxidation hair dyeing agent composition HOYU 05 Dec, 2019
KAO GERMANY
EP2922532B1 5-aminosalicylic acid capsule formulation ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD 05 Dec, 2019
(Expiration: Nov, 2033)
WIBBELMANN
EP2868318B2 Injectable formulation OTSUKA PHARMACEUTICAL 04 Dec, 2019
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP2854746B1 Composition COSMETIC WARRIORS 28 Nov, 2019
HENKEL
EP3182958B2 Aripiprazole prodrug compositions ALKERMES PHARMA IRELAND 27 Nov, 2019
GENERICS UK
EP2280687B1 Chewing gum compositions comprising cannabinoids STICHTING SANAMMAD 27 Nov, 2019
(Expiration: Mar, 2029)
MEDCAN PHARMA
EP2658399B2 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection ABBOTT LABORATORIES 27 Nov, 2019
NUTRICIA
(and 1 more)
EP3269717B9 Polymorphic and pseudopolymorphic forms of pharmaceutical compound nxl104 PFIZER IRELAND PHARMACEUTICALS 26 Nov, 2019
(Expiration: Oct, 2030)
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP3114943B1 Non-allergenic food product NUTRICIA NV 26 Nov, 2019
(Expiration: Aug, 2027)
SOCIT DES PRODUITS NESTL
EP2773361B1 Method for improving executive function NUTRICIA 25 Nov, 2019
SOCIT DES PRODUITS NESTL
EP2711024B1 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same UNITED THERAPEUTICS CORP 22 Nov, 2019
(Expiration: Sep, 2028)
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
EP2928496B1 Crispr-based genome modification and regulation SIGMA ALDRICH CO LLC 22 Nov, 2019
(Expiration: Dec, 2033)
VOSSIUS & PARTNER PATENTANWLTE RECHTSANWLTE MBB
(and 7 more)
EP2939688B1 Pharmaceutical compositions comprising botulinum neurotoxin IPSEN BIOPHARM 20 Nov, 2019
ALLERGAN
EP3003277B1 Process for the preparation of a pharmaceutical composition comprising rivaroxaban SANDOZ AG 20 Nov, 2019
(Expiration: May, 2034)
HGF
EP2451445B1 Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient BOEHRINGER INGELHEIM INTERNATIONAL GMBH 20 Nov, 2019
(Expiration: Jul, 2030)
TEVA PHARMACEUTICAL INDUSTRIES
(and 2 more)
EP2444027B2 Implant coated with net-shaped or island-shaped low-crystallized hydroxyapatite and method for coating same OSSTEMIMPLANT 20 Nov, 2019
WYNNE JONES
EP2527457B1 Widespread gene delivery to motor neurons using peripheral injection of aav vectors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS 19 Nov, 2019
(Expiration: Oct, 2028)
BEZZUBOVA
EP2481420B1 Single dose anti-PCV2 pig vaccine BOEHRINGER INGELHEIM ANIMAL HEALTH USA 19 Nov, 2019
(Expiration: Dec, 2027)
CEVA SANTE ANIMALE
(and 1 more)
EP1622470B1 Alginate matrix particles GIVAUDAN SA 19 Nov, 2019
(Expiration: May, 2024)
OMYA
EP1856051B1 Amorphous lercanidipine hydrochloride RECORDATI IRELAND LTD 13 Nov, 2019
(Expiration: Feb, 2026)
GLENMARK LIFE SCIENCES
(and 6 more)
EP2886108B2 Optimised pharmaceutical formula for the treatment of inflammatory changes of the esophagus DR FALK PHARMA 06 Nov, 2019
ADARE
EP3103784B1 Manufacture of an oil-in-water emulsion comprising squalene SEQIRUS UK 06 Nov, 2019
GLAXOSMITHKLINE BIOLOGICALS
EP2958544B1 Soft solid oil-in-water emulsion comprising a mixture of nonionic surfactants, a water-soluble polysaccharide and a wax comprising at least one ester LORAL 06 Nov, 2019
HENKEL
(and 1 more)
EP2773338B1 Improving recognition NUTRICIA NV 05 Nov, 2019
(Expiration: Oct, 2032)
SOCIT DES PRODUITS NESTL
EP3226827B2 Aluminium-free antiperspirant/deodorant compositions and method of preparing the same STOCKHOLMS ANALYTISKA LABORATORIUM 29 Oct, 2019
HENKEL
(and 1 more)
EP2925350B1 Enhancing anti-cancer activity of immunomodulatory fc fusion proteins BRISTOL MYERS SQUIBB 29 Oct, 2019
PLOUGMANN VINGTOFT
EP2774606B1 Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV SYNTHON BV 28 Oct, 2019
(Expiration: Feb, 2034)
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
(and 4 more)
EP3109258B1 Recombinant rsv antigens GLAXOSMITHKLINE BIOLOGICALS SA 23 Oct, 2019
(Expiration: Dec, 2028)
PFIZER
(and 1 more)
EP2934698B1 Trans-resveratrol or trans-resveratrol derivative composition LORAL 22 Oct, 2019
IPAZ
EP2731947B1 Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes BOEHRINGER INGELHEIM 16 Oct, 2019
(Expiration: Jul, 2032)
BRCHER
EP2962690B1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof AMGEN EUROPE 16 Oct, 2019
DR REDDYS LABORATORIES
(and 14 more)
EP2348832B1 Preservative system for emulsion-based therapeutic topical formulations ARBOR PHARMACEUTICALS 16 Oct, 2019
GENERICS UK
EP3140011B2 Aqueous cosmetic powder composition KAO GERMANY 16 Oct, 2019
HENKEL
EP2277597B1 Reductive colour removal HENKEL 16 Oct, 2019
LORAL
EP3126381B2 Claudin-6-specific immunoreceptors and t cell epitopes BIONTECH CELL&GENE THERAPIES 16 Oct, 2019
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
EP2988757B2 Treatment of skin injuries associated with auto-immune and inflammatory diseases using the arsenic compound as2o5 CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS 15 Oct, 2019
MEDSENIC
EP2900236B2 Treatment of wolfram syndrome-related neurodegeneration THE UNIVERSITY OF BIRMINGHAM 15 Oct, 2019
NEUROFIX SL
EP1617823B1 A pouch comprising a nicotine composition for transmucosal delivery NICACHET AB 09 Oct, 2019
(Expiration: Jan, 2024)
KELTIE
EP3094631B1 Pyrimidinyloxy benzene derivatives as herbicides FMC 09 Oct, 2019
MAINSTAY
EP2099480B1 Microorganisms of fractions thereof capable of activating cellular immunity against carbohydrates TE BIOS 09 Oct, 2019
PATENT BOUTIQUE
EP3270970B1 Gelling esterified cellulose ethers DOW 09 Oct, 2019
SHIN ETSU CHEMICAL
EP3271404B1 Water-soluble esterified cellulose ethers DOW 09 Oct, 2019
SHIN ETSU CHEMICAL
EP3270971B1 Water-soluble esterified cellulose ethers having a low degree of neutralization DOW 09 Oct, 2019
SHIN ETSU CHEMICAL
EP2981275B1 Lozenge for the treatment of throat pain, hoarseness and associated dry cough, as well as inflammatory diseases of the mouth and pharynx SANOFI AVENTIS DEUTSCHLAND GMBH 09 Oct, 2019
(Expiration: Mar, 2034)
STREHLKE
EP3270973B1 Aqueous solution of an esterified cellulose ether DOW 08 Oct, 2019
SHIN ETSU CHEMICAL
EP2464337B1 Pharmaceutical composition and administrations thereof VERTEX PHARMACEUTICALS INCORPORATED 07 Oct, 2019
TEVA PHARMACEUTICAL INDUSTRIES
EP2299989B1 Stabilized transdermal drug delivery system MYLAN 02 Oct, 2019
AMW
EP2794014B1 Product for temporarily shaping keratin fibers on the basis of a combination of specific film-forming polymers HENKEL AG AND CO KGAA 02 Oct, 2019
(Expiration: Nov, 2032)
LOREAL
EP2676679B1 Formulations which stabilize and inhibit precipitation of immunogenic compositions WYETH 02 Oct, 2019
MERCK SHARP & DOHME
(and 2 more)
EP3210591B1 Compositions and methods for targeted thermomodulation SEBACIA 02 Oct, 2019
SEBACIA
EP2925282B1 Mild antibacterial cleansing compositions UNILEVER 01 Oct, 2019
BEIERSDORF
EP2535355B1 Antibodies against CD38 for treatment of multiple myeloma GENMAB AS 01 Oct, 2019
(Expiration: Mar, 2026)
SECERNA
EP2368914B1 Anti-5T4 antibodies and uses thereof WYETH LLC 01 Oct, 2019
(Expiration: Mar, 2027)
SYNTHON BIOPHARMACEUTICALS
EP2922598B2 Sensorily attractive hydrodispersion having waxes BEIERSDORF 30 Sep, 2019
HENKEL
EP2785374B2 Recombinant gallid herpesvirus 3 (mdv serotype 2) vectors expressing antigens of avian pathogens and uses thereof BOEHRINGER INGELHEIM ANIMAL HEALTH USA 30 Sep, 2019
(Expiration: Nov, 2032)
INTERVET
EP2421841B1 Improved method of achieving and maintaining a specified alkylene oxide production parameter with a high efficiency catalyst DOW TECHNOLOGY INVESTMENTS LLC 26 Sep, 2019
(Expiration: Apr, 2030)
BASF
EP2827845B1 Compositions comprising a delivery agent and preparation thereof NOVO NORDISK AS 26 Sep, 2019
(Expiration: Mar, 2033)
CMS CAMERON MCKENNA NABARRO OLSWANG
(and 4 more)
EP2359869B1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same and uses therefor THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 26 Sep, 2019
GRUND
EP3185962B1 Multi-tonal one step dyeing with thickened pre-treatment solution ii HENKEL 26 Sep, 2019
KAO GERMANY
EP2888290B1 Novel esterified cellulose ethers of high molecular weight and homogeneity DOW 26 Sep, 2019
SHIN ETSU CHEMICAL
EP3140320B1 Peptide vaccine comprising mutant ras peptide and chemotherapeutic agent TARGOVAX SOLUTIONS 26 Sep, 2019
STRAWMAN
EP2598151B1 Compositions for treating heartworm infestation CEVA SANTE ANIMALE SA 25 Sep, 2019
(Expiration: Jul, 2031)
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP2958541B1 Gel-type cosmetic composition LOREAL 25 Sep, 2019
HENKEL
EP2640853B1 Modulation of alpha synuclein expression IONIS PHARMACEUTICALS 25 Sep, 2019
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3020730B1 Anti-il1rap antibodies and their use for treating human CANTARGIA 25 Sep, 2019
MAB DISCOVERY
EP2962686B1 Dosage form containing oxycodone and naloxone EURO CELTIQUE SA 24 Sep, 2019
(Expiration: Feb, 2026)
KRKA
(and 6 more)
EP3205338B1 Method of producing enteric soft capsule FUJI CAPSULE 19 Sep, 2019
CP KELCO APS
EP1477189B1 Process for production of pressure-sensitive adhesive moldings comprising crosslinked polymers as the main component HISAMITSU PHARMACEUTICAL CO INC 19 Sep, 2019
(Expiration: Jan, 2023)
LTS LOHMANN THERAPIE SYSTEME
EP2731626B1 Photosensitizing antibody-fluorophore conjugates THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES 18 Sep, 2019
STRAWMAN
EP3056514B1 Methods for manipulating phagocytosis mediated by cd47 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 16 Sep, 2019
KNIG SZYNKA TILMANN VON RENESSE
(and 3 more)
EP3056515B1 Methods for manipulating phagocytosis mediated by cd47 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 16 Sep, 2019
KNIG SZYNKA TILMANN VON RENESSE
(and 3 more)
EP3206873B1 Laminate changing device LUYE SUPPLY 12 Sep, 2019
STRAWMAN
EP2531218B1 Immunoglobulin preparation CSL BEHRING 11 Sep, 2019
UCB BIOPHARMA SPRL
EP3070090B1 Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile INCYTE HOLDINGS CORP 06 Sep, 2019
(Expiration: Jun, 2028)
GENERICS UK
EP3143995B1 Rapamycin derivative for the treatment of lung cancer NOVARTIS PHARMA 05 Sep, 2019
(Expiration: Feb, 2022)
ACCORD HEALTHCARE
(and 6 more)
EP3250185B1 Ophthalmic suspension composition BAUSCH AND LOMB INC 05 Sep, 2019
(Expiration: Jan, 2036)
EUROPEAN OPPOSITIONS
(and 2 more)
EP2874630B1 Dosing regimen for janus kinase (jak) inhibitors ZOETIS SERVICES LLC 05 Sep, 2019
(Expiration: Jul, 2033)
KRKA
EP2176357B1 A colouring composition comprising starch derivatives as a hydrocolloid CHR HANSEN NATURAL COLORS AS 05 Sep, 2019
(Expiration: Jul, 2028)
SENSIENT COLORS EUROPE
(and 1 more)
EP2734175B1 Use, as antiperspirant, of a polyvalent cation salt without aluminium halide antiperspirant or compound capable of reacting with said salt in order to produce an antiperspirant effect LOREAL 04 Sep, 2019
BEIERSDORF
EP3052131B1 Methods for treating cancer in patients with elevated levels of bim MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 04 Sep, 2019
MERCK PATENT
(and 1 more)
EP2658546B1 Methods of using human milk oligosaccharides for improving airway respiratory health ABBOTT LABORATORIES 04 Sep, 2019
(Expiration: Dec, 2031)
SOCIT DES PRODUITS NESTL
EP3204045B1 Pharmaceutical formulations for the oral delivery of peptide or protein drugs CYPRUMED GMBH 03 Sep, 2019
(Expiration: Oct, 2035)
SANOFI
EP3031466B1 Purified amphiphilic peptide compositions and uses thereof 3D MATRIX INC 28 Aug, 2019
(Expiration: Jul, 2025)
ARCH THERAPEUTICS
EP3082746B1 Shaping keratin fibres using an amine or a diamine THE PROCTER & GAMBLE 28 Aug, 2019
LOREAL
EP2486806B1 Stevia composition PURECIRCLE USA INC 28 Aug, 2019
(Expiration: Aug, 2031)
SAGITTARIUS CONSULTANTS
EP2301516B1 Aerosol compositions with stabilised particulate materials BEIERSDORF 28 Aug, 2019
UNILEVER
EP2968152B2 Methods and systems for conditioning of particulate crystalline materials PEARL THERAPEUTICS 28 Aug, 2019
VECTURA
EP3342411B1 Rapamycin derivative for treating pancreas cancer NOVARTIS PHARMA AG 27 Aug, 2019
(Expiration: Feb, 2022)
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTEL
(and 9 more)
EP3119436B1 Sheet-like structure for the controlled release of active substances CARL FREUDENBERG KG 27 Aug, 2019
(Expiration: Mar, 2035)
MAHLE
EP3191084B2 Solid dosage form production UNIVERSITY OF CENTRAL LANCASHIRE 27 Aug, 2019
MERCK PATENT
EP2299984B1 Oral formulations of cytidine analogs and methods of use thereof CELGENE 27 Aug, 2019
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
EP3017811B1 Apixaban formulations BRISTOL MYERS SQUIBB IRELAND UNLIMITED 27 Aug, 2019
TEVA PHARMACEUTICAL INDUSTRIES
(and 8 more)
EP2797570B1 Use for reduced staining and improved washability BEIERSDORF AG 23 Aug, 2019
(Expiration: Dec, 2032)
THE PROCTER & GAMBLE
EP2988722B1 Composition comprising henna and/or indigo, an oil and a saccharide, and hair dyeing process using the same LOREAL SA 22 Aug, 2019
(Expiration: Apr, 2034)
COTY
EP2282758B1 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders BIOARCTIC 21 Aug, 2019
CARPMAELS & RANSFORD SPECIALITIES
(and 2 more)
EP2833866B1 Soft chewable pharmaceutical products INTERVET 21 Aug, 2019
CEVA SANTE ANIMALE
(and 1 more)
EP3111957B1 Magnesium oxide granules for pharmaceutical applications or food additive applications KONOSHIMA CHEMICAL 21 Aug, 2019
DEAD SEA BROMINE
EP2664328B2 Omega3 fatty acid compound preparation MOCHIDA PHARMACEUTICAL 21 Aug, 2019
FH SERVICES
EP2869813B1 Syringe NOVARTIS AG 21 Aug, 2019
(Expiration: Jan, 2033)
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
(and 1 more)
EP2961486B2 Multi-tonal one step dyeing ii HENKEL 21 Aug, 2019
LOREAL
(and 1 more)
EP2970677B1 Small scale microencapsulated pigments and uses thereof CHROMATIC TECHNOLOGIES INC 21 Aug, 2019
(Expiration: Mar, 2034)
SOCIT BIC
EP3167900B1 Vaccine against streptococci MERIAL LTD 20 Aug, 2019
(Expiration: Mar, 2027)
AWA SWEDEN
EP2207507B1 Once-a-day replacement transdermal administration of fentanyl ALZA CORP 20 Aug, 2019
(Expiration: Oct, 2028)
HEXAL
EP3027063B1 Opo glyceride composition BUNGE LODERS CROKLAAN BV 20 Aug, 2019
(Expiration: Jul, 2034)
NEDERLANDSCH OCTROOIBUREAU
(and 1 more)
EP2313087B2 Pharmaceutical dosage form for immediate release of an indolinone derivative BOEHRINGER INGELHEIM 20 Aug, 2019
(Expiration: Jun, 2029)
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
(and 2 more)
EP1846030B1 Fixed dosing of her antibodies GENENTECH INC 19 Aug, 2019
(Expiration: Jun, 2025)
BREUER
(and 3 more)
EP2482841B2 Compositions and methods for enhancing coagulation factor viii function THE CHILDRENS HOSPITAL OF PHILADELPHIA 16 Aug, 2019
STRAWMAN
(and 2 more)
EP2824181B1 Novel fgfr3 fusion product ASTELLAS PHARMA INC 14 Aug, 2019
(Expiration: Mar, 2033)
BOULT WADE TENNANT
(and 1 more)
EP3209381B1 Compositions comprising bacterial strains 4D PHARMA RESEARCH LTD 14 Aug, 2019
(Expiration: Nov, 2036)
BRADY
(and 1 more)
EP3071219B1 Methods of treating antibody-mediated rejection in organ transplant patients with c1-esterase inhibitor TAKEDA PHARMACEUTICAL 14 Aug, 2019
CSL INNOVATION
EP2748192B2 Novel kif5b-ret fusion molecules and uses thereof FOUNDATION MEDICINE 14 Aug, 2019
JAMES POOLE
(and 1 more)
EP3078667B1 Formulation of boronic acid compounds THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES 14 Aug, 2019
LEK PHARMACEUTICALS DD
(and 10 more)
EP1793855B2 Prevention and treatment of synucleinopathic and amyloidogenic disease PROTHENA BIOSCIENCES 14 Aug, 2019
MATHYS & SQUIRE
EP2981271B1 Therapeutic uses of empagliflozin BOEHRINGER INGELHEIM 14 Aug, 2019
(Expiration: Apr, 2034)
STADA ARZNEIMITTEL
(and 7 more)
EP3102605B1 Combination of a pd-1 antagonist and a vegfr inhibitor for treating cancer MERCK SHARP AND DOHME LLC 14 Aug, 2019
(Expiration: Feb, 2035)
WITHERS & ROGERS
(and 1 more)
EP3060303B1 Mrna therapy for argininosuccinate synthetase deficiency TRANSLATE BIO INC 14 Aug, 2019
(Expiration: Oct, 2034)
WITHERS & ROGERS
EP2298279B1 Pharmaceutical compositions for inhalation VECTURA LTD 12 Aug, 2019
(Expiration: Nov, 2021)
GLAXO GROUP
EP2714000B2 Composition comprising an alkoxysilane and a modified starch, and cosmetic use thereof LOREAL 12 Aug, 2019
HENKEL
EP2934160B1 Low viscosity, high caloric density oral nutritional composition and related methods ABBOTT LABORATORIES 12 Aug, 2019
NUTRICIA RESEARCH
(and 1 more)
EP3033070B1 Process for treating keratin fibres using an aqueous-alcoholic composition comprising an organic monoacid LORAL 09 Aug, 2019
KAO GERMANY
EP3141254B1 Lactobacillus rhamnosus rht-3201 conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseases ILDONG PHARMACEUTICAL 08 Aug, 2019
SOCIT DES PRODUITS NESTL
EP3045176B8 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydroisoindol-2-yl)-piperidine-2,6-dione CELGENE CORP 07 Aug, 2019
(Expiration: Sep, 2024)
GENERICS UK
EP3045175B8 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydroisoindol-2-yl)-piperidine-2,6-dione CELGENE CORP 07 Aug, 2019
(Expiration: Sep, 2024)
GENERICS UK
EP3042659B8 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydroisoindol-2-yl)-piperidine-2,6-dione CELGENE CORP 07 Aug, 2019
(Expiration: Sep, 2024)
GENERICS UK
(and 4 more)
EP2956146B2 Stem cell microparticles and mirna RENEURON 07 Aug, 2019
PAJARO
EP1832179B1 Carbohydrate composition and flat glucose response NUTRICIA NV 07 Aug, 2019
(Expiration: Dec, 2025)
SOCIT DES PRODUITS NESTL
EP2736487B1 New (trimethoxyphenylamino)pyrimidinyl formulations RIGEL PHARMACEUTICALS 07 Aug, 2019
TEVA PHARMACEUTICAL INDUSTRIES
EP2879649B2 Dyeing composition comprising at least one fatty substance, at least one oxidizing agent and at least one non-ionic, anionic and amphoteric surfactant LOREAL 06 Aug, 2019
HENKEL
EP3017827B1 Pneumococcal polysaccharide conjugate vaccine GLAXOSMITHKLINE BIOLOGICALS 06 Aug, 2019
(Expiration: Dec, 2026)
SK BIOSCIENCE
(and 2 more)
EP3087852B1 Oral pouched product having a rectangular shape SWEDISH MATCH NORTH EUROPE 06 Aug, 2019
SKRUF SNUS
(and 2 more)
EP2673237B1 Microporous zirconium silicate for the treatment of hyperkalemia ZS PHARMA 05 Aug, 2019
TEVA PHARMACEUTICAL INDUSTRIES
(and 2 more)
EP2850189B8 Compositions and methods for modulating gene expression GENERAL HOSPITAL CORP 02 Aug, 2019
(Expiration: May, 2033)
ROCHE INNOVATION CENTER COPENHAGEN
EP2983697B1 Treatment of diabetes mellitus by long acting formulations of insulins SANOFI SA 31 Jul, 2019
(Expiration: Apr, 2034)
COOKE
EP2964202B2 Oral formulations of deferasirox NOVARTIS 31 Jul, 2019
(Expiration: Mar, 2034)
INVOKAT SERVICES
(and 2 more)
EP2512425B1 Cleansing composition KAO GERMANY GMBH 31 Jul, 2019
(Expiration: Dec, 2030)
LOREAL
EP2611422B1 Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD 31 Jul, 2019
(Expiration: Aug, 2031)
SANDOZ
(and 2 more)
EP1803444B1 A method for the preparation of a nicotine-containing particulate material with a crystalline cellulose (in particular mcc) NICONOVUM 31 Jul, 2019
SWEDISH MATCH NORTH EUROPE
(and 1 more)
EP3160228B1 Synergistic antimicrobial composition of zinc pyrithione JUBILANT INGREVIA 31 Jul, 2019
THE PROCTER & GAMBLE
EP1565201B1 Methods of administering dalbavancin for treatment of bacterial infections VICURON PHARMACEUTICALS 30 Jul, 2019
FRESENIUS KABI DEUTSCHLAND
EP3033079B1 Methods for the treatment of her2 amplified cancer PHARMACYCLICS LLC 30 Jul, 2019
(Expiration: Aug, 2034)
GENERICS UK
EP2877147B1 Process UNILEVER 30 Jul, 2019
HENKEL
EP2694049B1 Tapentadol for preventing chronification of pain GRUENENTHAL GMBH 29 Jul, 2019
(Expiration: Apr, 2032)
HEXAL
(and 1 more)
EP2072054B1 Use of a ginkgo biloba leaf extract DR WILLMAR SCHWABE 29 Jul, 2019
KRNZLE
(and 3 more)
EP2968241B1 Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications UNIVERSITY OF FLORIDA RESEARCH FOUNDATION 29 Jul, 2019
NEDERLANDSCH OCTROOIBUREAU
EP1803443B1 A method for the preparation of a nicotine-containing particulate material with a crystalline cellulose (in particular mcc) NICONOVUM 26 Jul, 2019
PHILIP MORRIS PRODUCTS
(and 1 more)
EP2920248B1 Surface-modified calcium oxide KALKFABRIK NETSTAL 25 Jul, 2019
SCHAEFER KALK
EP2784084B2 Antagonist antibodies to IL-17A/F heterologous polypeptides NOVARTIS PHARMA AG 24 Jul, 2019
(Expiration: Jun, 2024)
NOVARTIS
(and 3 more)
EP3122878B1 Mrna therapy for the treatment of ocular diseases TRANSLATE BIO 24 Jul, 2019
PRFER & PARTNER MBB
EP2568967B2 Pharmaceutical compositions comprising hydromorphone and naloxone EURO CELTIQUE 23 Jul, 2019
ALGOBATE
(and 1 more)
EP2874647B1 Method of diagnosis and treatment of metastatic cancer LA TROBE UNIVERSITY 23 Jul, 2019
(Expiration: Jul, 2033)
GRUND
EP2750707B1 Pegylated liposomes for delivery of immunogen-encoding rna GLAXOSMITHKLINE BIOLOGICALS SA 23 Jul, 2019
(Expiration: Aug, 2032)
MLLER
(and 1 more)
EP3025705B8 Stable ivabradine formulations SANOFI ILAC SANAYI VE TICARET AS 22 Jul, 2019
(Expiration: Nov, 2034)
HGF
EP1848422B1 Method for decreasing cartilage damage in dogs HILLS PET NUTRITION INC 19 Jul, 2019
(Expiration: Feb, 2026)
IAMS EUROPE
(and 1 more)
EP3229799B1 Crystalline forms of trisodium supramolecular complex comprising valsartan and ahu-377 and methods thereof CRYSTAL PHARMATECH 17 Jul, 2019
D YOUNG
EP3196301B1 Methods and compositions for the treatment of monogenic diseases SANGAMO THERAPEUTICS INC 17 Jul, 2019
(Expiration: Mar, 2033)
LEEMING
(and 2 more)
EP2081669B8 Granules, tablets and granulation ATACAMA LABS 17 Jul, 2019
OMYA
EP2852370B1 Radiance compositions and methods of use JOHNSON AND JOHNSON CONSUMER INC 16 Jul, 2019
(Expiration: May, 2032)
HENKEL
EP2724728B1 Complexes of il-15 and il-15r alpha and uses thereof NOVARTIS AG 16 Jul, 2019
(Expiration: Jun, 2028)
HGF
EP3065731B1 Methods and compositions for improving kidney function HILLS PET NUTRITION INC 16 Jul, 2019
(Expiration: Nov, 2033)
IAMS EUROPE
EP2345400B1 Lightening compositions having reduced hair damage HENKEL AG AND CO KGAA 16 Jul, 2019
(Expiration: Nov, 2030)
KAO GERMANY
EP2753187B1 Method for preventing and/or treating insulin resistance CAELUS PHARMACEUTICALS 15 Jul, 2019
STRAWMAN
EP2380552B1 Emulsion composition, and food and cosmetic each containing the emulsion composition FUJIFILM 10 Jul, 2019
DSM NUTRITIONAL PRODUCTS
EP2968243B1 Nutritional supplement targeting meibomian glands PRN PHYSICIAN RECOMMENDED NUTRICEUTICALS 10 Jul, 2019
GEORGIOU
EP2723195B1 Method for reducing the occurrence of infection in young children NUTRICIA 10 Jul, 2019
SOCIT DES PRODUITS NESTL
(and 1 more)
EP1784222B1 Nutritional composition comprising indigestible oligosaccharides NUTRICIA NV 10 Jul, 2019
(Expiration: Aug, 2025)
SOCIT DES PRODUITS NESTL
EP1747001B1 Management of breakthrough bleeding in extended hormonal contraceptive regimens BAYER 10 Jul, 2019
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
(and 1 more)
EP2768964B1 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens INTERVET 09 Jul, 2019
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP2882454B1 Combination therapy for the treatment of glioblastoma F HOFFMANN LA ROCHE AG 09 Jul, 2019
(Expiration: Aug, 2033)
DRRIES
(and 2 more)
EP2586319B1 Composition comprising flavouring substances and organic acids and use thereof VETAGRO 09 Jul, 2019
DSM NUTRITIONAL PRODUCTS
EP2884973B1 Buffer substance for the treatment of wounds PAUL HARTMANN 09 Jul, 2019
KCI LICENSING
EP2515992B1 Swallowable drug delivery device and methods of drug delivery RANI THERAPEUTICS 09 Jul, 2019
NOVO NORDISK
EP2269603B1 Treatment of breast tumors with a rapamycin derivative in combination with exemestane NOVARTIS PHARMA GMBH 08 Jul, 2019
(Expiration: Feb, 2022)
ZENTIVA FRANCE
(and 8 more)
EP2036546B1 Psychostimulant containing pharmaceutical composition PEJO ISERLOHN HEILMITTEL UND DIT & COKG 05 Jul, 2019
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP3009143B1 Progranulin for use in treating parkinson's disease or alzheimer's disease NEURODYN LIFE SCIENCES INC 03 Jul, 2019
(Expiration: Jan, 2029)
CMS CAMERON MCKENNA NABARRO OLSWANG
(and 1 more)
EP2805625B2 Nutritional composition with probiotics NUTRICIA 03 Jul, 2019
HOFFMANN EITLE
EP2793831B2 Cosmetic composition comprising an anionic surfactant, a solid fatty alcohol and a solid fatty ester, and cosmetic treatment process LORAL 02 Jul, 2019
BEIERSDORF
(and 2 more)
EP2297207B1 Use of anti-factors xi antibodies for prevention of thrombus formation PROTHIX 02 Jul, 2019
MATHYS & SQUIRE
EP3214091B1 Use of chimeric antigen receptor-modified t cells to treat cancer UNIVERSITY OF PENNSYLVANIA PENN 02 Jul, 2019
(Expiration: Dec, 2031)
MDECINS DU MONDE ET AL
(and 3 more)
EP2156751B8 Novel sweetener having sugar-like taste and production method and use of the same MATSUTANI CHEMICAL INDUSTRY 01 Jul, 2019
HANNA MOORE & CURLEY
EP3184526B1 Pyrrolo[2,3-d]pyrimidine derivatives as janus kinase inhibitor INCYTE 28 Jun, 2019
CONCERT PHARMACEUTICALS
EP3086782B1 Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus DR FALK PHARMA 26 Jun, 2019
ADARE
EP2322153B1 Use of HIF Alpha stabilizers for enhancing erythropoiesis FIBROGEN INC 26 Jun, 2019
(Expiration: Jun, 2024)
GLAXOSMITHKLINE UK
(and 3 more)
EP3025719B1 Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases MILTENYI BIOTEC GMBH 26 Jun, 2019
(Expiration: Nov, 2035)
HOFFMANN EITLE
EP2723304B1 Cleaning composition comprising a gelling agent and a foaming surfactant ESSITY OPERATIONS FRANCE 25 Jun, 2019
HENKEL
EP2285410B1 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation BOEHRINGER INGELHEIM INTERNATIONAL GMBH 25 Jun, 2019
(Expiration: Apr, 2029)
HEXAL
(and 3 more)
EP2882687B1 Method for producing stabilized amorphous calcium carbonate AMORPHICAL 24 Jun, 2019
SCHAEFER KALK
EP2696861B1 Combination of epa, dpa and/or dha with a chemotherapeutic agent NUTRICIA NV 21 Jun, 2019
(Expiration: Apr, 2032)
FRESENIUS KABI DEUTSCHLAND
EP3060195B1 Cosmetic composition based on hyaluronic acid, method of preparation and use thereof CONTIPRO AS 21 Jun, 2019
(Expiration: Oct, 2034)
STELLENBOSCH NANOFIBER
EP3027186B1 Composition comprising hyaluronic acid and mepivacaine TEOXANE 21 Jun, 2019
VIVACY
(and 2 more)
EP2785308B2 Novel hair cleansing composition LORAL 20 Jun, 2019
BEIERSDORF
EP2608784B1 Treatment or prevention of heart failure in a mammal receiving anti-coagulant therapy NOVARTIS AG 19 Jun, 2019
(Expiration: Aug, 2031)
ALFRED E TIEFENBACHER
(and 2 more)
EP2576578B1 Polymorphs of 2'-o-fucosyllactose and producing thereof GLYCOM AS 19 Jun, 2019
(Expiration: Jun, 2031)
BASF
EP3058958B1 Anidulafungin composition SELECTCHEMIE AG 19 Jun, 2019
(Expiration: Feb, 2036)
COOKE
EP2744477B1 Methods of enhancing skin hydration and improving non-diseased skin THE PROCTER & GAMBLE 19 Jun, 2019
HENKEL
EP2282978B1 Lithium silicate glass ceramic and method for fabrication of dental appliances JAMES R GLIDEWELL DENTAL CERAMICS 19 Jun, 2019
IVOCLAR VIVADENT
EP2794017B1 Substance for dyeing keratin fibers, containing cationic anthraquinone dyes and fatty acid triglycerides HENKEL 19 Jun, 2019
LOREAL
EP3212667B1 Pharmaceutical anti-tnf-alpha antibody formulation RICHTER GEDEON NYRT 19 Jun, 2019
SAMSUNG BIOEPIS UK
(and 1 more)
EP3105317B1 Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells CELLECTIS 19 Jun, 2019
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
(and 1 more)
EP3305302B1 Compositions and methods for modulation of smn2 splicing in a subject BIOGEN MA 19 Jun, 2019
TAYLOR WESSING
EP2896628B1 Process for efficient purification of neutral human milk oligosaccharides (hmos) from microbial fermentation CHR HANSEN HMO 18 Jun, 2019
GREAVES BREWSTER
(and 4 more)
EP2776066B1 Rank/rankl antagonists for use in treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies UNIVERSITE LAVAL 18 Jun, 2019
(Expiration: Nov, 2032)
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
EP3238749B1 Tissue plug D MATRIX 18 Jun, 2019
POTTER CLARKSON
EP2916856B2 Uses of bremelanotide in therapy for female sexual dysfunction PALATIN 18 Jun, 2019
TEVA PHARMACEUTICAL INDUSTRIES
EP3294270B1 Pharmaceutical composition containing rifaximin alpha&delta SANDOZ AG 12 Jun, 2019
(Expiration: Mar, 2037)
ALFRED E TIEFENBACHER
(and 1 more)
EP2647707B1 Cytotoxicity-inducing therapeutic agent CHUGAI PHARMACEUTICAL CO LTD 12 Jun, 2019
(Expiration: Nov, 2031)
BOEHRINGER INGELHEIM RCV BOEHRINGER INGELHEIM
(and 4 more)
EP2958916B1 Solid forms of a selective cdk4/6 inhibitor PFIZER INC 12 Jun, 2019
(Expiration: Feb, 2034)
GENERICS UK
(and 2 more)
EP2867245B1 Purification of iduronate-2-sulfatase TAKEDA PHARMACEUTICAL 12 Jun, 2019
HGF
EP1771192B1 Use of aspartate for regulating glucose levels in blood NUTRICIA NV 11 Jun, 2019
(Expiration: Jul, 2025)
FRESENIUS KABI DEUTSCHLAND
EP3166641B1 A process for the preparation of formulations for inhalation ARVEN ILAC SANAYI VE TICARET 11 Jun, 2019
VECTURA
EP2359800B1 Composition for cosmetic treatment of keratin fibres comprising volatile linear alkanes, C8-30 fatty alcohols and mono- or polyglycosides LOREAL SA 07 Jun, 2019
(Expiration: Dec, 2030)
HENKEL
EP2806851B2 Composition comprising at least one specific alkoxysilane polymer LOREAL 05 Jun, 2019
HENKEL
EP2903458B1 Methods for enhancing the effect of egcg on mitigating skeletal muscle loss ABBOTT LABORATORIES 05 Jun, 2019
NUTRICIA
EP3019153B1 Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation CHIESI FARMACEUTICI 05 Jun, 2019
TEVA UK
EP2598118B1 Preservative free bimatoprost and timolol solutions ALLERGAN 04 Jun, 2019
ALFRED E TIEFENBACHER
(and 5 more)
EP3016654B1 Tauroursodeoxycholic acid (tudca) for use in the treatment of neurodegenerative disorders BRUSCHETTINI 04 Jun, 2019
AMMELBURG
EP2914248B2 Pharmaceutical compositions for the treatment of cftr mediated diseases VERTEX PHARMACEUTICALS INCORPORATED 04 Jun, 2019
GENERICS UK
EP2598119B1 Preservative free brimonidine and timolol solutions ALLERGAN INC 04 Jun, 2019
(Expiration: Jul, 2031)
INSTONE
(and 1 more)
EP2451300B2 Heat resistant probiotic compositions and healthy food comprising them DEGAMA PROBIOTICS 31 May, 2019
CHR HANSEN
EP2877146B1 Process UNILEVER 31 May, 2019
HENKEL
EP2877143B1 Process UNILEVER 31 May, 2019
HENKEL
EP2922818B1 Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules HANGZHOU DAC BIOTECH 31 May, 2019
STRAWMAN
(and 1 more)
EP3076997B1 Swine vaccine against prrs and lawsonia intracellularis INTERVET 29 May, 2019
BOEHRINGER INGELHEIM VETMEDICA
EP3166690B2 Improved decolorization of dyed keratin fibers HENKEL 29 May, 2019
LOREAL
EP2976359B2 Methods for treating osteogenesis imperfecta GENZYME 29 May, 2019
SAGITTARIUS CONSULTANTS
EP2609812B1 Liquid nucleotides/nucleosides-containing product NUTRICIA NV 29 May, 2019
(Expiration: Mar, 2028)
SOCIT DES PRODUITS NESTL
EP2968351B1 Opioid receptor modulator dosage formulations ALLERGAN UNLIMITED 28 May, 2019
SANDOZ
EP2566954B2 Immunotherapy using redirected allogeneic cells YEDA RESEARCH 27 May, 2019
GRUND
EP3351246B8 Rapamycin derivative for the treatment of a solid tumor associated with deregulated angiogenesis NOVARTIS PHARMA AG 23 May, 2019
(Expiration: Feb, 2022)
STADA ARZNEIMITTEL
(and 9 more)
EP2952191B1 Sublingual apomorphine SUNOVION PHARMACEUTICALS 22 May, 2019
D YOUNG
EP2597968B1 Process for modifying the properties of citrus fiber CARGILL INCORPORATED 22 May, 2019
RICHLY
(and 1 more)
EP2872488B1 Crystalline forms of a prolyl hydroxylase inhibitor FIBROGEN 22 May, 2019
SANDOZ
(and 2 more)
EP3127542B1 Antiviral therapy VIIV HEALTHCARE 22 May, 2019
STADA ARZNEIMITTEL
(and 3 more)
EP3021820B1 Antiperspirant spray devices and compositions PROCTER AND GAMBLE CO 21 May, 2019
(Expiration: Jul, 2034)
BEIERSDORF
EP3093004B2 Sun protectant free of octocrylene with minimal stickyness BEIERSDORF 21 May, 2019
EMIL KIESSLING
EP2739153B1 Treatment of breast cancer MEDIVATION PROSTATE THERAPEUTICS 21 May, 2019
GENERICS UK
EP2688561B1 Transdermal compositions comprising an active agent layer and an active agent conversion layer TEIKOKU PHARMA USA INC 21 May, 2019
(Expiration: Mar, 2032)
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP2797573B1 Method of treating artificially coloured hair KAO GERMANY 20 May, 2019
HENKEL
EP3019146B1 Long-wear cosmetic composition LOREAL SA 17 May, 2019
(Expiration: Jul, 2034)
HENKEL
EP3056187B2 Single-dose pharmaceutical preparation of thyroid hormones t3 and/or t4 ALTERGON 17 May, 2019
UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES
EP2827885B1 Compositions of glp-1 peptides and preparation thereof NOVO NORDISK 15 May, 2019
(Expiration: Mar, 2033)
GALENICUM HEALTH SLU
(and 3 more)
EP2477645B1 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency APTALIS PHARMA 15 May, 2019
MATHYS & SQUIRE
EP2991671B1 Oral dosing of glp-1 compounds NOVO NORDISK 15 May, 2019
(Expiration: May, 2034)
SANOFI
(and 5 more)
EP2793877B2 Chewing gum products containing [(2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester WM WRIGLEY JR 14 May, 2019
AXALBION
EP2854790B1 Use of n-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media ARES TRADING SA 14 May, 2019
(Expiration: May, 2033)
FERRING
EP2864479B1 Modulation of ube3a-ats expression IONIS PHARMACEUTICALS 14 May, 2019
FHOFFMANN LA ROCHE
EP3121171B1 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine NOVARTIS 14 May, 2019
(Expiration: Dec, 2031)
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
EP2509566B2 Process for permanent shaping of human hair KAO GERMANY 13 May, 2019
HENKEL
EP2977372B1 Polymorphs of febuxostat SANDOZ AG 10 May, 2019
(Expiration: Jun, 2031)
ALFRED E TIEFENBACHER
EP3093007B1 Octocrylene-free sunscreen comprising diethylamino hydroxybenzoyl hexyl benzoate BEIERSDORF 09 May, 2019
LORAL
(and 2 more)
EP2964336B1 Colour changing composition in emulsion form comprising a partially neutralized, crosslinked acrylic homopolymer or copolymer LOREAL 08 May, 2019
BEIERSDORF
EP1925282B1 Low density cosmetic formulations, cosmetic products containing the same and methods of cosmetic treatment of hair, and/or skin using the same LOREAL SA 08 May, 2019
(Expiration: Nov, 2027)
HENKEL
EP2861304B1 Cosmetic compositions comprising hyaluronan biosynthesis promoting agents SYMRISE 08 May, 2019
MAYR KOTSCH PARTNERSCHAFTSGESELLSCHAFT MBB
EP2598121B1 A method of controlling the release of an active ingredient from a dosage form DOW GLOBAL TECHNOLOGIES LLC 08 May, 2019
(Expiration: Jun, 2031)
TYLOSE & COKG
EP2797576B1 Hair dyeing composition KAO GERMANY GMBH 07 May, 2019
(Expiration: Dec, 2032)
HENKEL
EP2863762B1 Method to convert insects or worms into nutrient streams and compositions obtained thereby BUHLER (CHANGZHOU) INSECT TECHNOLOGIES COLTD 07 May, 2019
(Expiration: Jun, 2033)
NEXTPROTEIN
(and 2 more)
EP2837407B1 Octocrylene-free, odour-stable sun protection agent BEIERSDORF AG 03 May, 2019
(Expiration: Jun, 2034)
BASF
(and 2 more)
EP2902029B1 Ret inhibitor CHUGAI SEIYAKU KABUSHIKI KAISHA 03 May, 2019
FRESENIUS KABI DEUTSCHLAND
EP3103498B2 Spray dispenser for nasal drugs AP PHARMA SYSTEMS ATOMIZADORES E DISPENSADORES LTDA 02 May, 2019
APTAR RADOLFZELL
EP1844763B2 Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment BIOSERENTACH 02 May, 2019
COSMED PHARMACEUTICAL
(and 1 more)
EP2381923B2 Safe desmopressin administration ACERUS PHARMACEUTICALS USA 01 May, 2019
FERRING
EP2498759B1 Immediate release tablet formulations ASTRAZENECA UK LTD 30 Apr, 2019
(Expiration: Nov, 2030)
GENERICS UK
(and 3 more)
EP3049157B2 Hair compositions comprising low viscosity silicone polymers THE PROCTER & GAMBLE 30 Apr, 2019
HENKEL
EP3108872B2 Hair cosmetic KAO 30 Apr, 2019
HENKEL
EP3066119B1 New method to concentrate von willebrand factor or complexes thereof CSL 30 Apr, 2019
HOFFMANN EITLE
EP2803366B1 Compositions for treating or preventing oxalate-related disease OXTHERA INTELLECTUAL PROPERTY AB 30 Apr, 2019
(Expiration: Jun, 2025)
POHLMAN
EP2683395B1 Use of low dose il-2 for treating autoimmune - related or inflammatory disorders ASSISTANCE PUBLIQUE HPITAUX DE PARIS 30 Apr, 2019
STRAWMAN
EP2994125B1 Nintedanib zur anwendung in der behandlung von nsclc BOEHRINGER INGELHEIM INTERNATIONAL GMBH 30 Apr, 2019
(Expiration: May, 2034)
TEVA PHARMACEUTICAL INDUSTRIES
(and 3 more)
EP3298040B1 Treatment of fibrosis SINGAPORE HEALTH SERVICES PTE 29 Apr, 2019
BAYER
EP3112376B1 Bifunctional polypeptides IMMUNOCORE LTD 29 Apr, 2019
(Expiration: May, 2030)
STORZ
EP2830622B1 A nicotine oral delivery product containing a powder enclosed in a water insoluble pouch, wherein said powder comprises nicotine and a chewing gum composition FNYZ 29 Apr, 2019
SWEDISH MATCH NORTH EUROPE
EP2818156B1 Perfumed cosmetic preparation BEIERSDORF AG 25 Apr, 2019
(Expiration: Mar, 2029)
DALLI WERKE
(and 1 more)
EP2498758B1 Bilayer tablet formulations ASTRAZENECA 25 Apr, 2019
(Expiration: Nov, 2030)
HOEFER & PARTNER PATENTANWLTE MBB
EP2570109B2 Cosmetic sun protection spray BEIERSDORF 24 Apr, 2019
BASF
(and 1 more)
EP3082963B1 Styling spray having a volume effect HENKEL 24 Apr, 2019
BEIERSDORF
EP2477638B1 Probiotic stabilization MJN US HOLDINGS LLC 24 Apr, 2019
(Expiration: Sep, 2030)
CHR HANSEN NATURAL COLORS
(and 1 more)
EP3016527B1 Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotella PROPREV 24 Apr, 2019
DUPONT NUTRITION BIOSCIENCES APS
EP2854802B2 Oil/water-emulsion-type topical compositions containing a retinoid GALDERMA RESEARCH 24 Apr, 2019
GENERICS UK
EP2950774B1 Dye composition using at least one coupler of meta-phenylenediamine type substituted in position 4 in a medium comprising a fatty substance, processes and device LOREAL 24 Apr, 2019
HENKEL
(and 1 more)
EP2931301B2 Process for purifying insulin and analogues thereof MERCK SHARP & DOHME 24 Apr, 2019
HERZOG
EP3054926B1 Hiv treatment formulation of atazanavir and cobicistat BRISTOL MYERS SQUIBB IRELAND UNLIMITED 24 Apr, 2019
TEVA PHARMACEUTICAL INDUSTRIES
EP2819701B2 Immunotherapeutic molecules and uses THE UNIVERSITY OF BIRMINGHAM 23 Apr, 2019
FHOFFMANN LA ROCHE
EP2931741B1 Porcine parvovirus 5a, methods of use and vaccine BOEHRINGER INGELHEIM VETMEDICA INC 23 Apr, 2019
(Expiration: Jan, 2034)
INTERVET
EP2757902B1 Interomone compositions and their use to modify behavior in different vertebrate species SERGEANTS PET CARE PRODUCTS 18 Apr, 2019
CEVA SANTE ANIMALE
EP2138154B1 Hair rinse with amphotenside and special storage life BEIERSDORF 18 Apr, 2019
HENKEL
EP3076928B1 Composition for oxidative colouring of hair, comprising specific combinations of developers and couplers HENKEL 18 Apr, 2019
LORAL
EP3076940B1 Agent for the oxidative dyeing of hair, containing specific combinations of developers and couplers HENKEL 18 Apr, 2019
LOREAL
EP2535053B1 Mitochondrial function improver KAO 18 Apr, 2019
NUTRICIA
EP2903636B1 Immunogenic compositions GLAXOSMITHKLINE BIOLOGICALS SA 18 Apr, 2019
(Expiration: Oct, 2033)
PFIZER
EP2954892B1 Solid compositions ABBVIE IRELAND ULC 17 Apr, 2019
(Expiration: Jun, 2031)
AECHTER
EP2766014B1 Methods of treating pediatric patients using dexmedetomidine HOSPIRA INC 16 Apr, 2019
(Expiration: Sep, 2032)
FRESENIUS KABI DEUTSCHLAND
EP2658510B1 Bleaching composition comprising a polyhydroxy carboxylic acid KAO GERMANY 16 Apr, 2019
HENKEL
EP2996670B1 Transparent bleaching compositions with proteins and/or silicone oils HENKEL 16 Apr, 2019
KAO GERMANY
(and 1 more)
EP2421541B1 Novel use CLASADO INC 11 Apr, 2019
(Expiration: Apr, 2030)
NUTRICIA
EP2345425B1 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs LFB SA 11 Apr, 2019
(Expiration: Dec, 2026)
OCTAPHARMA
(and 1 more)
EP2368145B1 Ophthalmic devices for delivery of hydrophobic comfort agents ALCON 10 Apr, 2019
COOPERVISION
EP3199172B1 Dosing regimen for multiple sclerosis YEDA RESEARCH 10 Apr, 2019
HEXAL
(and 4 more)
EP2504353B2 Lipopeptide compositions and related methods CUBIST PHARMACEUTICALS 10 Apr, 2019
HGF
(and 1 more)
EP2806855B1 Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation CHIESI FARMACEUTICI 10 Apr, 2019
ZBM PATENTS
EP2833910B1 Pcv/mycoplasma hyopneumoniae combination vaccine ZOETIS SERVICES 04 Apr, 2019
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP3401400B1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 04 Apr, 2019
DF MP DRRIES FRANK MOLNIA & POHLMAN
(and 3 more)
EP2500014B1 Slow release pharmaceutical composition made of microparticles DEBIOPHARM 04 Apr, 2019
GENERICS UK
EP3220883B1 Composition comprising salt of acyl glutamate as primary surfactant or primary anionic surfactant UNILEVER 04 Apr, 2019
THE PROCTER & GAMBLE
EP2298301B2 Medicaments for increasing endogenous erythropoietin (epo) FIBROGEN 03 Apr, 2019
AKEBIA THERAPEUTICS
EP2289531B1 Medicaments for increasing endogenous erythropoietine (epo) FIBROGEN 03 Apr, 2019
AKEBIA THERAPEUTICS
(and 1 more)
EP2026880B1 Pharmaceutical and cosmetic use of silica BLAA LONID HF 03 Apr, 2019
BEIERSDORF
EP2991615B2 Hair care shampoo HENKEL 03 Apr, 2019
BEIERSDORF
EP2992897B1 Immunogenic compositions comprising lawsonia intercellularis BOEHRINGER INGELHEIM VETMEDICA INC 03 Apr, 2019
(Expiration: Mar, 2026)
CEVA SANTE ANIMALE
(and 1 more)
EP2025318B1 Two-phase composition for conditioning hair KAO GERMANY GMBH 01 Apr, 2019
(Expiration: Aug, 2028)
HENKEL
EP2496246B1 Composition, method, and kit for alpha-1 proteinase inhibitor GRIFOLS THERAPEUTICS LLC 27 Mar, 2019
(Expiration: Nov, 2030)
EUROPEAN OPPOSITIONS
EP2558092B1 Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase 6 (cdk4/6) inhibitor and an mtor inhibitor for treating cancer NOVARTIS AG 27 Mar, 2019
(Expiration: Apr, 2031)
GENERICS UK
EP2854803B2 Topical compositions in the form of a gel containing a particular solubilised retinoid GALDERMA RESEARCH 26 Mar, 2019
GENERICS UK
EP2630962B1 Low frequency glatiramer acetate therapy YEDA RESEARCH 26 Mar, 2019
G L PHARMA
(and 4 more)
EP3021833B2 Methods and formulations which allow the modulation of immune responses related to the administration of a biopharmaceutical drug HEXAL 26 Mar, 2019
MURPHY
EP3148510B1 Liquid pharmaceutical composition FRESENIUS KABI DEUTSCHLAND GMBH 26 Mar, 2019
(Expiration: May, 2035)
SAMSUNG BIOEPIS UK
(and 1 more)
EP2234612B1 Composition for stimulating natural killer cell activity NUTRICIA NV 25 Mar, 2019
(Expiration: Jan, 2029)
FRESENIUS KABI DEUTSCHLAND
EP2497461B2 Paediatric solutions comprising a beta-blocker PIERRE FABRE DERMATOLOGIE 20 Mar, 2019
AECHTER
EP2723758B1 Angiopoietin-like 3 (angptl3) irna compostions and methods of use thereof ALNYLAM PHARMACEUTICALS 19 Mar, 2019
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
EP2964675B1 Engager cells for immunotherapy BAYLOR COLLEGE OF MEDICINE 19 Mar, 2019
(Expiration: Mar, 2034)
SCHLICH
EP3049061B1 Composition comprising an organic liquid diluent and a specific hydroxyalkyl methylcellulose DOW 19 Mar, 2019
SHIN ETSU CHEMICAL
EP3216807B2 Coating composition containing methyl cellulose, method for producing the same, and solid preparation SHIN ETSU CHEMICAL 18 Mar, 2019
DUPONT NUTRITION BIOSCIENCES APS
EP2618801B2 Cosmetic composition comprising at least one hygroscopic salt, at least one aromatic polyol ether and at least one diol, and cosmetic treatment process LORAL 13 Mar, 2019
HENKEL
EP2139515B2 Attenuated viruses useful for vaccines THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK 13 Mar, 2019
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
EP2774481B1 Antimicrobial compositions SYMRISE 13 Mar, 2019
SCHLKE & MAYR
EP2337849B1 Factor ix polypeptide mutant, its uses and a method for its production UNIQURE BIOPHARMA BV 12 Mar, 2019
(Expiration: Sep, 2029)
BAXALTA
(and 4 more)
EP2307457B2 Stable and soluble antibodies inhibiting tnf NOVARTIS AG 12 Mar, 2019
(Expiration: Jun, 2029)
STRAWMAN
EP2772245B1 Ginger extract for the protection of stem cells SYMRISE 07 Mar, 2019
FLAVEX NATUREXTRAKTE
EP2658517B2 Improved powderous vitamin e formulations DSM ASSETS 06 Mar, 2019
BASF
EP2515887B1 Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine UCB BIOPHARMA 06 Mar, 2019
GENERICS UK
(and 1 more)
EP2482849B1 Combination immunotherapy for the treatment of cancer UNIVERSITY OF TEXAS SYSTEM 06 Mar, 2019
(Expiration: Sep, 2030)
GLAXOSMITHKLINE
(and 1 more)
EP2475432B2 Cosmetic composition with an antimicrobial effect DALLI WERKE 06 Mar, 2019
HENKEL
(and 1 more)
EP3062761B1 Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an hlb<8, and a c8-c18 branched alkane LOREAL 06 Mar, 2019
HENKEL
EP2782559B1 Pharmaceutical composition comprising myo-inositol and d-chiro-inositol LO LI PHARMA 06 Mar, 2019
VERCO
EP2925299B1 Novel pharmaceutical composition NOVARTIS AG 05 Mar, 2019
(Expiration: Nov, 2033)
GENERICS UK
EP2970101B1 Prodrugs of fumarates and their use in treating various deseases ALKERMES PHARMA IRELAND 05 Mar, 2019
TEVA PHARMACEUTICAL INDUSTRIES
(and 2 more)
EP2482822B1 Orally administered corticosteroid compositions ADARE PHARMACEUTICALS INC 01 Mar, 2019
(Expiration: Sep, 2030)
DR FALK PHARMA
EP2768322B1 Whey protein micelles against muscle atrophy and sarcopenia SOCIT DES PRODUITS NESTL 28 Feb, 2019
ARLA FOODS AMBA
(and 1 more)
EP2654789B1 Antibodies against human cd39 and use thereof OREGA BIOTECH 28 Feb, 2019
BOULT WADE TENNANT
(and 3 more)
EP1942939B2 Interleukin-13 antibody composition MEDIMMUNE 28 Feb, 2019
DERMIRA
EP2680885B8 Combination vaccines with lower doses of antigen and/or adjuvant GLAXOSMITHKLINE BIOLOGICALS SA 28 Feb, 2019
(Expiration: Mar, 2032)
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
EP1736139B1 Hair-treating agent and methods of treating hair KAO 28 Feb, 2019
HENKEL
EP2417199B1 Volatile oily composition BIOSYNTHIS 28 Feb, 2019
HENKEL
EP2914296B2 Treatment of cancers using pi3 kinase isoform modulators INFINITY PHARMACEUTICALS 28 Feb, 2019
HEXAL
EP2844667B1 Targeted/immunomodulatory fusion proteins and methods for making same BIOCON 28 Feb, 2019
HOFFMANN EITLE
EP3030218B1 Gel-like sun protection product containing fatty alcohols BEIERSDORF 28 Feb, 2019
LORAL
EP2616099B1 Immunogenic compositions GLAXOSMITHKLINE BIOLOGICALS SA 28 Feb, 2019
(Expiration: Sep, 2031)
PFIZER
EP2461802B2 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof SOFAR 28 Feb, 2019
TILLOTTS PHARMA
EP2444057B1 Hair treatment agent with a high proportion of bound water BEIERSDORF 27 Feb, 2019
HENKEL
EP2509565B1 Emulsifier-free, polymer-stabilised foam formulations NEUBOURG SKIN CARE GMBH AND CO KG 26 Feb, 2019
(Expiration: Dec, 2030)
HENKEL
EP2691112B1 Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments MERCK SHARP & DOHME 25 Feb, 2019
KNIG SZYNKA TILMANN VON RENESSE
(and 1 more)
EP3131582B1 Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases VERTEX PHARMACEUTICALS INCORPORATED 22 Feb, 2019
GENERICS UK
EP2296758B1 Hair conditioning composition comprising three kinds of silicones UNILEVER 22 Feb, 2019
HENKEL
EP3129106B2 Compositions and dispersions containing particles comprising a polymer LOREAL 22 Feb, 2019
HENKEL
EP3072398B1 Bifidobacterium longum and hippocampal bdnf expression NESTEC SA 22 Feb, 2019
(Expiration: Apr, 2029)
MORINAGA MILK INDUSTRY
EP2659892B1 Concomitant drug for improving cognitive function NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE 22 Feb, 2019
NUTRICIA
EP2575776B1 Process for making dry and stable hemostatic compositions BAXTER HEALTHCARE SA 21 Feb, 2019
(Expiration: Jun, 2031)
FERROSAN MEDICAL DEVICES
(and 1 more)
EP2772480B2 Hiv replication inhibitor SHIONOGI 21 Feb, 2019
HIVIH
EP2815753B1 Oral pharmaceutical composition TAIHO PHARMACEUTICAL 18 Feb, 2019
TEVA PHARMACEUTICAL INDUSTRIES
EP2658509B1 Hair colouring composition comprising gluconic acid and/or its salts KAO GERMANY GMBH 15 Feb, 2019
(Expiration: Dec, 2031)
HENKEL
EP3023095B2 Direct compression formulation and process NOVARTIS AG 15 Feb, 2019
(Expiration: Jan, 2025)
INNOVATE LEGAL SERVICES
(and 2 more)
EP2970484B2 Heterodimeric bispecific antibodies AMGEN 15 Feb, 2019
RICKER
EP2068846B1 Foaming granule and method for making same THE ANDERSONS 08 Feb, 2019
BAYER
EP1768646B1 Cosmetic sprays UNILEVER PLC 08 Feb, 2019
(Expiration: May, 2025)
HENKEL
EP3003330B1 Microbiota restoration therapy (mrt), compositions and methods of manufacture REBIOTIX INC 08 Feb, 2019
(Expiration: Jun, 2034)
STRAWMAN
EP2833909B1 Pcv/mycoplasma hyopneumoniae/prrs combination vaccine ZOETIS SERVICES 07 Feb, 2019
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP2552424B1 Process for preparing carrier particles for dry powders for inhalation CHIESI FARMACEUTICI 07 Feb, 2019
ZAKLADY FARMACEUTYCZNE POLPHARMA
(and 1 more)
EP1956014B1 Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same TEIJIN PHARMA LTD 06 Feb, 2019
(Expiration: Jun, 2019)
DR SCHN
EP3113632B1 Liquid lactase compositions DSM ASSETS 04 Feb, 2019
CHR HANSEN
EP2822383B1 Antimicrobial compostion containing lauric acid and method for their production CARGILL INC 04 Feb, 2019
(Expiration: Mar, 2033)
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
(and 1 more)
EP3086761B1 Aqueous cosmetic composition comprising alkylcellulose, non-volatile oils, a hydrophilic gelling polymer and a polyol LOREAL SA 04 Feb, 2019
(Expiration: Dec, 2034)
HENKEL
EP2374472B9 Compositions and methods for treating ophthalmic disorders DYAX CORP 01 Feb, 2019
(Expiration: Mar, 2027)
BICYCLETX
(and 2 more)
EP2355902B1 Nutritional compositions with coated lipid globules NUTRICIA NV 01 Feb, 2019
(Expiration: Dec, 2029)
CARGILL
(and 1 more)
EP2618833B1 Breast cancer therapeutics IMBA INSTITUT FUR MOLEKULARE BIOTECHONOLOGIE GMBH 01 Feb, 2019
(Expiration: Sep, 2031)
DEHMEL & BETTENHAUSEN PATENTANWLTE PARTMBB
(and 1 more)
EP2822591B1 Pharmaceutical formulations of tnf-alpha antibodies CADILA HEALTHCARE LTD 01 Feb, 2019
(Expiration: Mar, 2033)
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
(and 1 more)
EP2849723B1 High-concentration monoclonal antibody formulations GENENTECH 31 Jan, 2019
BAYER BAYER
EP2687106B1 High energy liquid enteral nutritional composition NUTRICIA NV 30 Jan, 2019
(Expiration: Dec, 2028)
FRESENIUS KABI DEUTSCHLAND
(and 2 more)
EP2603100B1 Dry storage stabilizing composition for biological materials ADVANCED BIONUTRTION CORP 25 Jan, 2019
(Expiration: Aug, 2031)
CHR HANSEN
EP2526963B1 Stabilized Antibody-Containing Liquid Formulations CHUGAI PHARMACEUTICAL CO LTD 25 Jan, 2019
(Expiration: Jan, 2031)
HEXAL SANDOZ
EP2403520B1 Insulin formulations for rapid uptake ELI LILLY AND CO 25 Jan, 2019
(Expiration: Mar, 2030)
MAIKOWSKI & NINNEMANN PATENTANWLTE PARTNERSCHAFT MBB
(and 1 more)
EP3119385B2 Composition comprising cinnamaldehyde and zinc to improve swallowing SOCIT DES PRODUITS NESTL 24 Jan, 2019
NUTRICIA
EP2592950B2 Isomaltulose for use in enhancing mental performance SDZUCKER MANNHEIMOCHSENFURT 23 Jan, 2019
NUTRICIA
EP2956129B1 Pharmaceutical compositions containing dexketoprofen and tramadol LABORATORIOS MENARINI 18 Jan, 2019
INTAS PHARMACEUTICALS
(and 1 more)
EP3022231B1 Cyclodextrin CURADEV PHARMA PVT 18 Jan, 2019
LIGAND PHARMACEUTICALS INCORPORATED
EP2033627B2 Use of a bifidobacterium species lysate for treating sensitive skin LOREAL 18 Jan, 2019
NUTRICIA
EP2858985B1 Crystalline forms of an androgen receptor modulator ARAGON PHARMACEUTICALS 18 Jan, 2019
SAGITTARIUS
(and 2 more)
EP3222266B1 Compositions and methods for targeted thermomodulation SIENNA BIOPHARMACEUTICALS INC 18 Jan, 2019
(Expiration: Aug, 2031)
SEBACIA
EP2081550B2 Coating capsules with active pharmaceutical ingredients RELIANT PHARMACEUTICALS 17 Jan, 2019
FH SERVICES
(and 1 more)
EP2792369B1 Bendamustine cyclopolysaccharide compositions SOFTKEMO PHARMA 17 Jan, 2019
INTAS PHARMACEUTICALS
EP1710259B1 Cosmetic composition thickened with an inverse latex SOCIETE DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC SA 17 Jan, 2019
(Expiration: Jan, 2019)
SNF
EP1810026B1 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 16 Jan, 2019
MERCK SHARP & DOHME
(and 1 more)
EP3112377B1 Bifunctional polypeptides IMMUNOCORE LTD 15 Jan, 2019
(Expiration: May, 2030)
MICHALSKI HTTERMANN & PARTNER PATENTANWLTE MBB
EP2789659B2 Photoluminescent pigment; cosmetic, paint composition, and resin composition containing same; and photoluminescent pigment production method NIPPON SHEET GLASS 11 Jan, 2019
BASF COLORS & EFFECTS
EP3021824B2 Antiperspirant spray devices and compositions THE PROCTER & GAMBLE 11 Jan, 2019
BEIERSDORF
(and 1 more)
EP3021825B1 Antiperspirant spray devices and compositions THE PROCTER & GAMBLE 11 Jan, 2019
BEIERSDORF
EP2283803B2 Two-part foam hair dye KAO 11 Jan, 2019
HENKEL
EP2648520B1 Dexmedetomidine premix formulation HOSPIRA INC 09 Jan, 2019
(Expiration: Jun, 2032)
FRESENIUS KABI DEUTSCHLAND
EP2459163B1 Skin protectant, particularly against hydrophobic (lipohilic) and against hydrophilic (lipophobic) harmful substances DEB 04 Jan, 2019
BEIERSDORF
EP2852375B1 Method of treating hair UNILEVER 04 Jan, 2019
LOREAL
EP2670429B1 Method for inactivation/removal of coagulation factors by precipitation OCTAPHARMA AG 04 Jan, 2019
(Expiration: Feb, 2032)
STRAWMAN
(and 1 more)
EP3021830B1 Compositions and methods for treating hair LOREAL 03 Jan, 2019
BEIERSDORF
EP2622971B1 Method for controlling the digestive coagulation of proteins NUTRICIA NV 03 Jan, 2019
(Expiration: Apr, 2030)
NESTEC
(and 2 more)
EP2575775B1 Process for making dry and stable hemostatic compositions BAXTER HEALTHCARE SA 02 Jan, 2019
(Expiration: Jun, 2031)
FERROSAN MEDICAL DEVICES
(and 1 more)
EP2934515B1 A pharmaceutical combination comprising binimetinib NOVARTIS AG 02 Jan, 2019
(Expiration: Dec, 2033)
FRESENIUS KABI DEUTSCHLAND
EP2530091B1 Anti-dll3 antibody CHUGAI SEIYAKU KABUSHIKI KAISHA 02 Jan, 2019
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
(and 2 more)